New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 10, 2014
06:56 EDTSLXPSalix price target raised to $192 from $126 at Piper Jaffray
Piper Jaffray raised its price target for Salix Pharmaceuticals shares to $192 to reflect the Cosmo merger and contribution from Xifaxan in diarrhea-predominant irritable bowel syndrome. Piper sees low FDA risk given the IBS data and reiterates an Overweight rating on the stock.
News For SLXP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for SLXP

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use